BMS-986235

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Healthy ParticipantsMediators of Inflammation

Phase 1

A Study of Experimental Medication BMS-986235 in Healthy Subjects

CompletedNCT03335553

Bristol-Myers SquibbMediators of Inflammation

Start: 2017-11-15End: 2021-07-02Updated: 2022-03-31

A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS-986235

WithdrawnNCT04464577

Bristol-Myers SquibbHealthy Participants

Start: 2021-04-01End: 2021-06-08Updated: 2022-03-25